VISICOL Side Effects

6234305-9 | Cerebral Infarction, Hemiplegia
on Jun 10, 2009 Male patient from JAPAN , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, hemiplegia. Visicol dosage: (50 Gm), Oral.

6220203-3 | Cerebral Infarction
Patient was taking Visicol (View Usage). Patient had the following side effects: cerebral infarction on Jun 03, 2009 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 50 Gm, Oral.

6214013-0 | Dehydration, Hypoaesthesia, Hypocalcaemia, Nephropathy, Renal Impairment
Adverse event was reported on Jun 01, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 64 years of age, After Visicol was administered, patient had the following side effects: dehydration, hypoaesthesia, hypocalcaemia, nephropathy, renal impairment. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6214011-7 | Colitis Ischaemic, Large Intestinal Ulcer, Proctalgia
on Jun 01, 2009 Female patient from JAPAN , 76 years of age, was diagnosed with endoscopy (What is endoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, large intestinal ulcer, proctalgia. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ROSUVASATATIN CALCIUM (View Rosuvasatatin Calcium Review and Rosuvasatatin Calcium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), MAGNESIUM CITRATE (View Magnesium Citrate Review and Magnesium Citrate Label ), SODIUM PISCOSULFATE (View Sodium Piscosulfate Review and Sodium Piscosulfate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ). Patient was hospitalized.


6209877-0 | Dehydration, Diarrhoea, Oedema Peripheral, Renal Failure Acute, Vomiting
on May 25, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with bowel preparation, colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: dehydration, diarrhoea, oedema peripheral, renal failure acute, vomiting. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), AMPICILLIN WITH SULBACTAM (View Ampicillin With Sulbactam Review and Ampicillin With Sulbactam Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), POLYCARBOPHIL CALCIUM (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6202670-4 | Blood Calcium Decreased, Blood Potassium Decreased, Hypoaesthesia, Musculoskeletal Stiffness
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood calcium decreased, blood potassium decreased, hypoaesthesia, musculoskeletal stiffness on May 15, 2009 from JAPAN Additional patient health information: Female patient , 33 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: Oral. During the same period patient was treated with MESALAZINE (View Mesalazine Review and Mesalazine Label ).

6199267-1 | Gastrointestinal Erosion, Hyperphosphataemia, Intestinal Perforation, Peritonitis, Refusal Of Treatment By Patient, Septic Shock
Adverse event was reported on May 19, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 3 Tab Q15 Min Total 20 Po) was diagnosed with bowel preparation and. Location: UNITED STATES , 62 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: gastrointestinal erosion, hyperphosphataemia, intestinal perforation, peritonitis, refusal of treatment by patient, septic shock. During the same period patient was treated with FLEETS ENEMA (Fleets Enema X2 Rectal) (View Fleets Enema Review and Fleets Enema Label ).

6194431-X | Areflexia, Depressed Level Of Consciousness, Dialysis, Electrocardiogram Qt Prolonged, Hyperphosphataemia, Hypocalcaemia, Malaise, Muscular Weakness, Pain
on May 13, 2009 Male patient from JAPAN , 81 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: areflexia, depressed level of consciousness, dialysis (What is dialysis?), electrocardiogram qt prolonged, hyperphosphataemia, hypocalcaemia, malaise, muscular weakness, pain (What is pain?). Visicol dosage: 50 Gm, Oral. During the same period patient was treated with NIFEDIPINE (Oral) (View Nifedipine Review and Nifedipine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6187696-1 | Cerebral Infarction, Hypocalcaemia, Nephropathy
on May 07, 2009 Female patient from JAPAN , 64 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: cerebral infarction, hypocalcaemia, nephropathy. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6187695-X | Areflexia, Depressed Level Of Consciousness, Hyperphosphataemia, Hypocalcaemia, Muscular Weakness, Tetany
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: areflexia, depressed level of consciousness, hyperphosphataemia, hypocalcaemia, muscular weakness, tetany on May 07, 2009 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with NIFEDIPINE (Oral) (View Nifedipine Review and Nifedipine Label ), VALSARTAN (Oral) (View Valsartan Review and Valsartan Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6175493-2 | Renal Failure Acute
Adverse event was reported on Apr 28, 2009 by a Male patient taking Visicol (View Usage) (Dosage: 50 Gm,oral) . Location: JAPAN , 69 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ). Patient was hospitalized.

6172818-9 | Delirium, Fall, Gait Disturbance, Loss Of Consciousness
on Apr 24, 2009 Male patient from JAPAN , 46 years of age, was diagnosed with colonoscopy (What is colonoscopy?), depression (What is depression?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: delirium, fall (What is fall?), gait disturbance, loss of consciousness. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with AMITRIPTLINE HYDROCHLORIDE TAB (75 Mg) (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ), IMIPRAMINE HYDROCHLORIDE (75 Mg) (View Imipramine Hydrochloride Review and Imipramine Hydrochloride Label ), PERPHENAZINE (6 Mg) (View Perphenazine Review and Perphenazine Label ), BROMAZEPAM (6 Mg) (View Bromazepam Review and Bromazepam Label ), TRAZODONE HCL (75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ), MIANSERIN HYDROCHLORIDE (30 Mg) (View Mianserin Hydrochloride Review and Mianserin Hydrochloride Label ), FLUNITRAZEPAM (2 Mg) (View Flunitrazepam Review and Flunitrazepam Label ), CHLORPROMAZINE (12.5 Mg) (View Chlorpromazine Review and Chlorpromazine Label ).

6169381-5 | Cerebral Infarction, Hypoaesthesia, Hypocalcaemia, Nephropathy, Renal Impairment
on Apr 23, 2009 Female patient from JAPAN , 64 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, hypoaesthesia, hypocalcaemia, nephropathy, renal impairment. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6165742-9 | Cardiomegaly, Eating Disorder, Kidney Enlargement, Nephropathy, Pleural Effusion, Renal Failure Chronic
Patient was taking Visicol (View Usage). Patient had the following side effects: cardiomegaly, eating disorder (What is eating disorder?), kidney enlargement, nephropathy, pleural effusion, renal failure chronic on Apr 20, 2009 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6162807-2 | Blood Calcium Decreased, Blood Potassium Decreased, Hypoaesthesia, Musculoskeletal Stiffness
Adverse event was reported on Apr 16, 2009 by a Female patient taking Visicol (View Usage) (Dosage: Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 33 years of age, After Visicol was administered, patient had the following side effects: blood calcium decreased, blood potassium decreased, hypoaesthesia, musculoskeletal stiffness. During the same period patient was treated with MESALAZINE (View Mesalazine Review and Mesalazine Label ).

6159214-5 | Blood Creatinine Increased, Blood Urea Increased
on Apr 13, 2009 Male patient from JAPAN , 55 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ).

6149124-1 | Blood Calcium Decreased, Hypoaesthesia
on Apr 03, 2009 Female patient from JAPAN , 32 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: blood calcium decreased, hypoaesthesia. Visicol dosage: Oral. During the same period patient was treated with MESALAZINE (View Mesalazine Review and Mesalazine Label ). Patient was hospitalized.

6140972-0 | Blood Creatinine Increased, Blood Urea Increased
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood creatinine increased, blood urea increased on Mar 26, 2009 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ).

6140969-0 | Delirium, Fall, Gait Disturbance, Loss Of Consciousness, Speech Disorder
Adverse event was reported on Mar 30, 2009 by a Male patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 46 years of age, Patient experienced the following unwanted or unexpected effects: delirium, fall (What is fall?), gait disturbance, loss of consciousness, speech disorder. During the same period patient was treated with AMITRIPTYLINE HCL (75 Mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), IMIPRAMINE HYDROCHLORIDE (75 Mg) (View Imipramine Hydrochloride Review and Imipramine Hydrochloride Label ), PERPHENAZINE (6 Mg) (View Perphenazine Review and Perphenazine Label ), BROMAZEPAM (6 Mg) (View Bromazepam Review and Bromazepam Label ), TRAZODONE HCL (75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ), MIANSERIN HYDROCHLORIDE (30 Mg) (View Mianserin Hydrochloride Review and Mianserin Hydrochloride Label ), FLUNITRAZEPAM (2 Mg) (View Flunitrazepam Review and Flunitrazepam Label ), CHLORPROMAZINE (12.5 Mg) (View Chlorpromazine Review and Chlorpromazine Label ).

6140761-7 | Areflexia, Depressed Level Of Consciousness, Hyperphosphataemia, Hypocalcaemia, Tetany
on Mar 30, 2009 Male patient from JAPAN , 81 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: areflexia, depressed level of consciousness, hyperphosphataemia, hypocalcaemia, tetany. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with NIFEDIPINE (Oral) (View Nifedipine Review and Nifedipine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALSARTAN (Oral) (View Valsartan Review and Valsartan Label ).

6128543-3 | Cardiomegaly, Hypophagia, Kidney Enlargement, Nausea, Nephropathy, Pleural Effusion, Renal Failure Chronic
on Mar 17, 2009 Female patient from JAPAN , 65 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: cardiomegaly, hypophagia, kidney enlargement, nausea (What is nausea?), nephropathy, pleural effusion, renal failure chronic. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6123741-7 | Loss Of Consciousness
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness on Mar 12, 2009 from JAPAN Additional patient health information: Male patient , 46 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and. Visicol dosage: (50 Tablets), Oral. During the same period patient was treated with AMITRIPTYLINE HCL (75 Mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), IMIPRAMINE HYDROCHLORIDE (75 Mg) (View Imipramine Hydrochloride Review and Imipramine Hydrochloride Label ), PERPHENAZINE (6 Mg) (View Perphenazine Review and Perphenazine Label ), BROMAZEPAM (6 Mg) (View Bromazepam Review and Bromazepam Label ), TRAZODONE HCL (75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ), MIANSERIN HYDROCHLORIDE (30 Mg) (View Mianserin Hydrochloride Review and Mianserin Hydrochloride Label ), FLUNITRAZEPAM (2 Mg) (View Flunitrazepam Review and Flunitrazepam Label ).

6122179-6 | Colitis Ischaemic
Adverse event was reported on Mar 12, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with endoscopy (What is endoscopy?) and. Location: JAPAN , 76 years of age, Patient had the following side effects: colitis ischaemic. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), MAGNESIUM CITRATE (View Magnesium Citrate Review and Magnesium Citrate Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ). Patient was hospitalized.

6121269-1 | Blood Phosphorus Increased, Renal Failure Acute, Renal Failure Chronic, Therapeutic Response Decreased
on Mar 12, 2009 Male patient from JAPAN , 69 years of age, was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood phosphorus increased, renal failure acute, renal failure chronic, therapeutic response decreased. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ). Patient was hospitalized.

6121267-8 | Dehydration, Diarrhoea, Oedema Peripheral, Renal Failure Acute, Vomiting
on Mar 11, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, oedema peripheral, renal failure acute, vomiting. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), AMPICILLIN WITH SULBACTAM (View Ampicillin With Sulbactam Review and Ampicillin With Sulbactam Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), POLYCARBOPHIL CALCIUM (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6097129-1 | Cerebral Infarction, Hypoaesthesia, Hypocalcaemia, Renal Impairment
Patient was taking Visicol (View Usage). Patient had the following side effects: cerebral infarction, hypoaesthesia, hypocalcaemia, renal impairment on Feb 23, 2009 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with bowel preparation and. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6088166-1 | Blood Calcium Decreased, Blood Pressure Decreased, Hypoaesthesia, Malaise, Renal Failure Acute
Adverse event was reported on Feb 13, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 85 years of age, After Visicol was administered, patient had the following side effects: blood calcium decreased, blood pressure decreased, hypoaesthesia, malaise, renal failure acute. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ECABET (View Ecabet Review and Ecabet Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ), LACTOMIN (View Lactomin Review and Lactomin Label ).

6079643-8 | Hypophagia, Kidney Enlargement, Nausea, Nephropathy, Renal Failure
on Feb 09, 2009 Female patient from JAPAN , 65 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: hypophagia, kidney enlargement, nausea (What is nausea?), nephropathy, renal failure. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6060119-9 | Dehydration, Diarrhoea, Diverticulitis, Renal Failure Acute
on Jan 01, 2008 Male patient from JAPAN , 49 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: dehydration, diarrhoea, diverticulitis, renal failure acute. Visicol dosage: (50 Gm),oral. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), AMPICILLIN WITH SULBACTAM (View Ampicillin With Sulbactam Review and Ampicillin With Sulbactam Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), POLYCARBOPHIL CALCIUM (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CLOSTRIDIUM BUTYRICUM (View Clostridium Butyricum Review and Clostridium Butyricum Label ). Patient was hospitalized.

6049975-8 | Asthenia, Dehydration, Influenza, Myalgia, Renal Impairment
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: asthenia, dehydration, influenza, myalgia, renal impairment on Jan 15, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 28 Tablets, Oral. During the same period patient was treated with DULCOLAX (View Dulcolax Review and Dulcolax Label ), ACTOS (View Actos Review and Actos Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

6044941-0 | Asthenia, Influenza, Myalgia, Renal Impairment, Renal Injury
Adverse event was reported on Jan 16, 2009 by a Male patient taking Visicol (View Usage) (Dosage: ) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: UNITED STATES , 66 years of age, weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, influenza, myalgia, renal impairment, renal injury. Patient was hospitalized.

6035198-5 | Cardiac Failure, Hypokalaemia, Oedema Peripheral
on Jan 08, 2009 Female patient from JAPAN , 89 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient had the following side effects: cardiac failure, hypokalaemia, oedema peripheral. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FLUTAZOLAM (View Flutazolam Review and Flutazolam Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6028710-3 | Colitis Ischaemic, Large Intestinal Ulcer Haemorrhage
on Dec 26, 2008 Male patient from JAPAN , 75 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: colitis ischaemic, large intestinal ulcer haemorrhage. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE ((10 Milligram/milliliters), Oral) (View Sodium Picosulfate Review and Sodium Picosulfate Label ), MOSAPRIDE CITRATE (TABLETS) (View Mosapride Citrate (tablets) Review and Mosapride Citrate (tablets) Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), MEXILENTINE HYDROCHLORIDE (View Mexilentine Hydrochloride Review and Mexilentine Hydrochloride Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6028707-3 | Beta 2 Microglobulin Increased, Body Temperature Increased, Cyanosis, Feeling Cold, Malaise, Protein Urine Present, Renal Failure Acute, Renal Tubular Necrosis, White Blood Cell Count Increased
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: beta 2 microglobulin increased, body temperature increased, cyanosis, feeling cold, malaise, protein urine present, renal failure acute, renal tubular necrosis, white blood cell count increased on Dec 26, 2008 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with COLICHINE (View Colichine Review and Colichine Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), IRSOGLADINE MALEATE (View Irsogladine Maleate Review and Irsogladine Maleate Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ), LACTOMIN (View Lactomin Review and Lactomin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6028704-8 | Blood Calcium Decreased, Blood Pressure Decreased, Gastric Ulcer, Hypoaesthesia, Malaise, Renal Failure Acute
Adverse event was reported on Dec 26, 2008 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 85 years of age, Patient had the following side effects: blood calcium decreased, blood pressure decreased, gastric ulcer, hypoaesthesia, malaise, renal failure acute. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ECABET (View Ecabet Review and Ecabet Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ), LACTOMIN (View Lactomin Review and Lactomin Label ).

6021233-7 | Infrequent Bowel Movements, Metabolic Acidosis, Nephrolithiasis, Renal Failure Acute, Weight Increased
on Dec 19, 2008 Male patient from JAPAN , 83 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: infrequent bowel movements, metabolic acidosis, nephrolithiasis, renal failure acute, weight increased. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ). Patient was hospitalized.

6020702-3 | Anxiety, Blood Potassium Decreased, Dehydration, Hypoaesthesia, Nausea, Paralysis Flaccid, Thirst
on Dec 19, 2008 Female patient from JAPAN , 56 years of age, was diagnosed with endoscopy (What is endoscopy?), preoperative care and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood potassium decreased, dehydration, hypoaesthesia, nausea (What is nausea?), paralysis flaccid, thirst. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), ATORVASTATIN BESILATE (View Atorvastatin Besilate Review and Atorvastatin Besilate Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE BESILATE (View Amlodipine Besilate Review and Amlodipine Besilate Label ), SODIUM RISEDRONATE HYDRATE (View Sodium Risedronate Hydrate Review and Sodium Risedronate Hydrate Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ). Patient was hospitalized.

6006107-X | Colitis Ischaemic, Intestinal Ischaemia, Large Intestinal Ulcer Haemorrhage
Patient was taking Visicol (View Usage). Patient had the following side effects: colitis ischaemic, intestinal ischaemia, large intestinal ulcer haemorrhage on Dec 11, 2008 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with bowel preparation, colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), NIZANTIDINE (View Nizantidine Review and Nizantidine Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ). Patient was hospitalized.

6003682-6 | Melaena, Post Procedural Haemorrhage
Adverse event was reported on Dec 11, 2008 by a Male patient taking Visicol (View Usage) (Dosage: (50 Gm), Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 66 years of age, After Visicol was administered, patient had the following side effects: melaena, post procedural haemorrhage. During the same period patient was treated with MITIGLINIDE CALCIUM HYDRATE (View Mitiglinide Calcium Hydrate Review and Mitiglinide Calcium Hydrate Label ), LAFUTIDINE (View Lafutidine Review and Lafutidine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

5989604-2 | Anxiety, Blood Potassium Decreased, Dehydration, Hypoaesthesia, Nausea, Paralysis, Paralysis Flaccid, Thirst
on Dec 03, 2008 Female patient from JAPAN , 56 years of age, was diagnosed with endoscopy (What is endoscopy?), preoperative care and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood potassium decreased, dehydration, hypoaesthesia, nausea (What is nausea?), paralysis (What is paralysis?), paralysis flaccid, thirst. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), ATORVASTATIN BESILATE (View Atorvastatin Besilate Review and Atorvastatin Besilate Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), SOSIUM PICOSULFATE (View Sosium Picosulfate Review and Sosium Picosulfate Label ), AMLODIPINE BESILATE (View Amlodipine Besilate Review and Amlodipine Besilate Label ), SODIUM RISEDRONATE HYDRATE (View Sodium Risedronate Hydrate Review and Sodium Risedronate Hydrate Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ). Patient was hospitalized.

5985295-5 | Face Oedema, Infrequent Bowel Movements, Kidney Enlargement, Metabolic Acidosis, Oedema Peripheral, Pollakiuria, Renal Failure Acute, Weight Increased
on Nov 26, 2008 Male patient from JAPAN , 83 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). Patient had the following side effects: face oedema, infrequent bowel movements, kidney enlargement, metabolic acidosis, oedema peripheral, pollakiuria, renal failure acute, weight increased. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ). Patient was hospitalized.

5976729-0 | Blood Creatinine Increased, Blood Urea Increased, Hepatic Function Abnormal
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood creatinine increased, blood urea increased, hepatic function abnormal on Nov 21, 2008 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral.

5974223-4 | Cardiac Failure, Diverticulum, Hypokalaemia, Oedema Peripheral
Adverse event was reported on Nov 26, 2008 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm , Oral) was diagnosed with endoscopy (What is endoscopy?) and. Location: JAPAN , 89 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, diverticulum, hypokalaemia, oedema peripheral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FLUTAZOLAM (View Flutazolam Review and Flutazolam Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), MEGNESIUM OXIDE (View Megnesium Oxide Review and Megnesium Oxide Label ). Patient was hospitalized.

5974222-2 | Hypoaesthesia, Post Procedural Complication, Renal Failure Acute
on Nov 26, 2008 Male patient from JAPAN , 68 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: hypoaesthesia, post procedural complication, renal failure acute. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), TANDOSPIRONE CITRATE (View Tandospirone Citrate Review and Tandospirone Citrate Label ), DIHYDROERGOTOXINE MESILATE (View Dihydroergotoxine Mesilate Review and Dihydroergotoxine Mesilate Label ), BETAHISTINE MESILATE (View Betahistine Mesilate Review and Betahistine Mesilate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLOTIAZEPAM (View Clotiazepam Review and Clotiazepam Label ). Patient was hospitalized.

5972473-4 | Colitis Ischaemic
on Nov 18, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with endoscopy (What is endoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: colitis ischaemic. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ). Patient was hospitalized.

5964603-5 | Haematochezia, Intestinal Ischaemia
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: haematochezia, intestinal ischaemia on Nov 18, 2008 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

5957396-9 | Blood Phosphorus Increased, Electrolyte Imbalance, No Therapeutic Response, Renal Failure Acute
Adverse event was reported on Nov 11, 2008 by a Male patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) . Location: JAPAN , 69 years of age, Patient had the following side effects: blood phosphorus increased, electrolyte imbalance, no therapeutic response, renal failure acute. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ). Patient was hospitalized.

5954773-7 | Cyanosis, Feeling Cold, Malaise, Pyrexia, Renal Failure Acute, Renal Tubular Necrosis, White Blood Cell Count Increased
on Nov 07, 2008 Female patient from JAPAN , 57 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: cyanosis, feeling cold, malaise, pyrexia, renal failure acute, renal tubular necrosis, white blood cell count increased. Visicol dosage: 50 Gm,oral. During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), IRSOGLADINE MALEATE (View Irsogladine Maleate Review and Irsogladine Maleate Label ), DAI KENCHU TO (View Dai-kenchu-to Review and Dai-kenchu-to Label ), LACTOMIN (View Lactomin Review and Lactomin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

5954771-3 | Anxiety, Blood Potassium Decreased, Dehydration, Hypoaesthesia, Nausea, Paralysis Flaccid, Thirst
on Nov 04, 2008 Female patient from JAPAN , 56 years of age, was diagnosed with endoscopy (What is endoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood potassium decreased, dehydration, hypoaesthesia, nausea (What is nausea?), paralysis flaccid, thirst. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SODIUM RISEDRONATE HYDRATE (View Sodium Risedronate Hydrate Review and Sodium Risedronate Hydrate Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ). Patient was hospitalized.

5944611-0 | Renal Failure Acute
Patient was taking Visicol (View Usage). Patient had the following side effects: renal failure acute on Oct 31, 2008 from JAPAN Additional patient health information: Male patient , 69 years of age, . Visicol dosage: 50 Gm, Oral. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.